AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Tyrosine 177 of BCR protein plays a critical role in activation of the anti-apoptotic pathway, such as AKT, and in transformation of hematopoietic progenitor cells in CML [43].